Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple ...
Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa ...
Diagnosing Alzheimer’s, a neurodegenerative disease, is complicated and costly. A study in RI could help speed up the process ...
Denali Therapeutics (NASDAQ:DNLI) used an analyst call from the 2026 WORLD Symposium in San Diego to highlight new and ...
Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million ...
How Our Lab Is Helping Develop An Alzheimer's Test That Can Be Done At Home. Imagine diagnosing one of the most challenging ...
MedGenome unveils MetaSeq, a groundbreaking blood test capable of detecting over 1,400 pathogens in just five days, enhancing ...
MedGenome expands its infectious disease testing portfolio with MetaSeq, a single test that detects over 1,400 pathogens: Our Bureau, Bengaluru Thursday, February 5, 2026, 14:15 H ...
Explore how Epstein-Barr may link to multiple sclerosis, affecting nearly one million people in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results